1. Home
  2. SHMD vs ARMP Comparison

SHMD vs ARMP Comparison

Compare SHMD & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$4.70

Market Cap

279.8M

Sector

N/A

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$5.23

Market Cap

156.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHMD
ARMP
Founded
1864
N/A
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.8M
156.4M
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
SHMD
ARMP
Price
$4.70
$5.23
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
406.4K
100.4K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$2.40
52 Week High
$10.65
$14.98

Technical Indicators

Market Signals
Indicator
SHMD
ARMP
Relative Strength Index (RSI) 47.06 54.20
Support Level $3.81 $5.12
Resistance Level $5.63 $5.60
Average True Range (ATR) 0.37 0.46
MACD 0.00 0.13
Stochastic Oscillator 25.63 97.69

Price Performance

Historical Comparison
SHMD
ARMP

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: